# A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

> **NCT00978393** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 49 (actual)

## Conditions studied

- Metabolism and Nutrition Disorder
- Obesity

## Interventions

- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** liraglutide

## Key facts

- **NCT ID:** NCT00978393
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-16
- **Primary completion:** 2011-06-08
- **Final completion:** 2011-06-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978393, "A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00978393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*